Special Investigation Of J Zoloft For Panic Disorder Patients

Viatris

Status: Completed

Conditions: Panic Disorder

Treatments: Drug: Sertraline hydrochloride

Study type: Observational

Funder types: Industry

Identifiers

NCT00605917

A0501092

Details and patient eligibility

About

The objective of this surveillance is to collect information for panic disorder patients about 1) adverse drug reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.

Full description

All patients with panic disorder to whom an investigator prescribes the first sertraline hydrochloride should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 997 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients with panic disorder need to be taking sertraline hydrochloride in order to be enrolled in the surveillance.

Exclusion criteria

Patients not taking sertraline hydrochloride.

Trial design

997 participants in 1 patient group

Sertraline hydrochloride.

Description:

The patients of Panic disorder taking Sertraline hydrochloride.

Treatment:

Drug: Sertraline hydrochloride